Fewer People are Dying of Cancer
Fewer people are dying of cancer today than in the '90s- according to a new report from the American Cancer Society.
Fewer people are dying of cancer today than in the '90s- according to a new report from the American Cancer Society.
A Cooking Class Helps Fight Cancer
A woman teaches cooking classes to help prevent and battle cancer in conjunction with a non profit group called the Cancer Project.
A woman teaches cooking classes to help prevent and battle cancer in conjunction with a non profit group called the Cancer Project.
Doctors Warn of a Dramatic Increase in Cancer Patients
Doctors are warning of a dramatic increase in the number of cancer cases among the elderly and minorities within the next two decades.
Doctors are warning of a dramatic increase in the number of cancer cases among the elderly and minorities within the next two decades.
Farrah's Story
"Farrah's Story", an intimate look at actress Farrah Fawcett and her battle with cancer.
"Farrah's Story", an intimate look at actress Farrah Fawcett and her battle with cancer.
Elderly Cancer
Experts are calling for more cancer studies among the elderly population.
Experts are calling for more cancer studies among the elderly population.
World Cancer Report
The American Cancer Society, along with several other agencies, released the World Cancer Report. Experts estimate cancer will become the leading cause of death worldwide by 2010.
The American Cancer Society, along with several other agencies, released the World Cancer Report. Experts estimate cancer will become the leading cause of death worldwide by 2010.
What are the Different Types of Non-Hodgkin's Lymphoma?
Non-Hodgkin's lymphoma is a complex -- and often confusing -- group of diseases. Tune in for an expert overview of the biology of NHL, as well as its diagnosis and treatment.
Non-Hodgkin's lymphoma is a complex -- and often confusing -- group of diseases. Tune in for an expert overview of the biology of NHL, as well as its diagnosis and treatment.
NHL: A Survivor's Journey
As a behavioral psychologist, Brian Stabler knew a lot about dealing with emotional stress. But nothing prepared him for the challenge of lymphoma. Tune in to hear how he overcame NHL and the important lessons he learned in the process.
As a behavioral psychologist, Brian Stabler knew a lot about dealing with emotional stress. But nothing prepared him for the challenge of lymphoma. Tune in to hear how he overcame NHL and the important lessons he learned in the process.
Life With Non-Hodgkin's Lymphoma: One Woman's Story
Eileen Merle-Rao is a woman with non-Hodgkin's lymphoma who seemed to be losing her battle against the disease. Listen as Eileen explains why she is now looking forward to a future filled with possibilities.
Eileen Merle-Rao is a woman with non-Hodgkin's lymphoma who seemed to be losing her battle against the disease. Listen as Eileen explains why she is now looking forward to a future filled with possibilities.
Radioimmunotherapy: Safety Measures During Therapy
The newest strategy in the fight against cancer is to bring radiation directly to cancer cells by attaching it to targeted drug therapy. Listen in as experts explain the process step-by-step.
The newest strategy in the fight against cancer is to bring radiation directly to cancer cells by attaching it to targeted drug therapy. Listen in as experts explain the process step-by-step.
Measuring Success with Targeted Therapy for NHL
The newest strategy in the fight against cancer is to bring radiation directly to cancer cells by attaching it to targeted drug therapy. Listen in as experts explain the process step-by-step.
The newest strategy in the fight against cancer is to bring radiation directly to cancer cells by attaching it to targeted drug therapy. Listen in as experts explain the process step-by-step.
How To Choose the Best Treatment Option When Indolent NHL Returns
A discussion of deciding among lymphoma treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma
A discussion of deciding among lymphoma treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma
Monoclonal Antibodies in Aggressive NHL
Monoclonal antibodies, primarily rituxan are common treatments for Non Hodgkins Lymphoma. Read more about the treatment here.
Monoclonal antibodies, primarily rituxan are common treatments for Non Hodgkins Lymphoma. Read more about the treatment here.
A New Way to Attack NHL
One of the newest developments in the treatment of non-Hodgkin's lymphoma, or NHL, is radioimmunotherapy which uses drugs called monoclonal antibodies, similar to antibodies the immune system makes to fight infection.
One of the newest developments in the treatment of non-Hodgkin's lymphoma, or NHL, is radioimmunotherapy which uses drugs called monoclonal antibodies, similar to antibodies the immune system makes to fight infection.
Attacking NHL Early
Learn how Monoclonal antibodies are often used in initial treatment of indolent, or non-aggressive, or low-grade, or follicular non-Hodgkins lymphoma, or NHL.
Learn how Monoclonal antibodies are often used in initial treatment of indolent, or non-aggressive, or low-grade, or follicular non-Hodgkins lymphoma, or NHL.
Starting Targeted Therapy For Lymphoma: What Are The Options?
Drugs that hone in on cancer cells are the latest weapons used in the treatment of non-Hodgkin's lymphoma.
Drugs that hone in on cancer cells are the latest weapons used in the treatment of non-Hodgkin's lymphoma.
Treating Lymphoma: Will a Customized Vaccine Work?
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.
Treating Lymphoma: Will a Customized Vaccine Work?
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.